Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Canadian Health Industry News.
Press releases published on June 12, 2025
Aesthetics, Inc. Unveils Immersive Art Experience at Scripps La Jolla North Tower
EIN Presswire
·
June 12, 2025
New hospital tower integrates large-scale murals, original artwork, and nature-based themes to enhance healing and elevate the patient experience. LA JOLLA, CA, UNITED STATES, June 11, 2025 /EINPresswire.com/ -- Aesthetics, Inc., pioneers in healing …
Coheed & Cambria’s Josh Eppard announces mental health collaboration between Drum Set Confessional and HeartSupport
EIN Presswire
·
June 12, 2025
AUSTIN, TX, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- Coheed …
Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2025 EHA Congress
GlobeNewswire
·
June 12, 2025
Addition of TUS to standard of care VEN+AZA creates a well-tolerated and mutation agnostic frontline triple drug therapy for newly diagnosed AML AML patients with diverse mutations, including TP53-mutated/CK and FLT3-wildtype, safely achieved complete …
Rakovina Therapeutics to Attend BIO International Convention to Advance Strategic Partnering Opportunities
GlobeNewswire
·
June 12, 2025
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …
NetraMark Founder Coauthors New Publication on AI/ML Use in Clinical Trials, Alongside Authors From Leading Global Regulatory Organizations
GlobeNewswire
·
June 12, 2025
TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) solutions company transforming clinical trial design in the pharmaceutical …
DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in Ontario
GlobeNewswire
·
June 12, 2025
TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("”DiagnaMed” or “DMED") (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John …